Page 41 - Markets

SAT reverses Sebi decision, okays Ketan Parekh's cross-examination

In January, Sebi had issued an ex parte interim order-cum-show cause notice against 22 entities, including Salgaocar (the appellant) and Parekh

Sunil Singhania's Abakkus MF launches Flexi Cap Fund: Who should invest?

Abakkus Flexi Cap Fund is an open-ended equity scheme to invest in large, mid, and smallcap stocks

Asian Paints surges 25% in 2 months; brokerages see more upside in stock

Asian Paints share price moved higher by 2 per cent to ₹2,920.50 on the BSE in Tuesday's intraday trade

Vidya Wires IPO opens tomorrow: Bid or skip? Here's what experts suggest

The unlisted shares of Vidya Wires were trading at ₹57, commanding a grey market premium of ₹5 or 9.6 per cent on Tuesday

Breakout rally ahead? InCred Equities predicts 25% upside in Nifty SmallCap

Nifty SmallCap index outlook: The SmallCap index is on the verge of a breakout on technical charts with a one-year target of 21,300-22,200 -- a 20-25 per cent upside from current levels

SC rejects Reliance plea over ₹30 lakh fine for not disclosing Jio-FB deal

In June 2022, Sebi imposed a penalty of ₹30 lakh on Reliance Industries for not making a prompt clarification to stock exchanges regarding the Jio-Facebook deal

Ashok Leyland rallies 13% in 1 week; what's driving the auto stock price?

With GST rationalisation & pick up in government capex, CV volumes are likely to improve going forward (expectations of positive YoY growth in FY26), according to ICICI Securities.

Small, mid-sized real estate players may outperform: Emkay; check top bets

Best real estate stocks to buy: Emkay Global assigned a 'Buy' rating on Lodha Developers, Sunteck Realty, and Arvind Smartspaces, an 'Add' rating on DLF, and a 'Reduce' rating on Oberoi Realty

Nomura backs Indian AMCs amid retail surge; Nippon Life, HDFC AMC top picks

Nomura expects healthy net inflows to continue as AMCs roll out new offerings such as specialised investment funds (SIFs) and extend their reach deeper into tier-II and tier-III markets

Wakefit sets IPO price band at ₹185-195; check key dates, GMP, objective

Wakefit Innonvation aims to raise ₹1,288 crore through a fresh issue of 19.3 million shares, amounting to ₹377.18 crore, and an OFS of 46.8 million shares, amounting to ₹911.7 crore

Motilal Oswal says Adani Ports is set for multi-year expansion; here's why

The brokerage has retained its Buy rating on Adani Ports shares, with a revised target price of ₹1,770, implying a 16 per cent upside from the current market price of ₹1,531 per share

Mindspace REIT's acquisition value-accretive, says Nuvama; retains 'Buy'

Terming the transaction value-accretive, Nuvama analysts Parvez Qazi and Vasudev Ganatra have reiterated their 'Buy' rating on the REIT, with a DCF-based target price of ₹507

Meesho IPO opens Dec 3: Analysts recommend long-term buy; should you bid?

Analysts at SBI Securities and Arihant Capital have recommended that investors subscribe to the Meesho IPO with a long-term perspective.

Stocks to Watch today: RIL, Hero MotoCorp, Tech Mahindra, LIC, HUL, NMDC

Stocks to Watch Today, December 2, 2025: Hindalco Industries, Hindustan Unilever, NMDC, Vedant Fashions, AU Small Finance Bank, and Fineotex Chemical are among the top stocks to watch today

Near-term margins for cement companies to remain under pressure

Weak Q3 pricing persists despite Y-o-Y profit gains, as aggressive capacity expansion overshadows near-term demand

Ravelcare IPO booked 7x on Day 1; strong retail demand, GMP at 40%

Ravelcare IPO received bids for 9.22 million equity shares compared to the issue size of 1.32 million shares

Wockhardt soars 19% on huge volumes; here's why the pharma stock rose today

The company said the United States Food and Drug Administration (USFDA) has formally accepted the New Drug Application (NDA) for its first-in-class antibiotic 'Zaynich'

Vidya Wires IPO opens Dec 3; GMP up 19%: Check price band, key dates, more

Vidya Wires IPO will open for subscription on Wednesday, December 3, 2025, and close on Friday, December 5, 2025

Aequs IPO opens Dec 3: Know key strengths, risks before you invest

Aequs IPO will be offered at a price band of ₹118 to ₹124 per share and a lot size of 120 shares

Natco Pharma share price rises 5% on rating update; check key details here

Natco Pharma, in a regulatory filing, has informed the exchanges that the credit rating agency ICRA Limited has reaffirmed and assigned credit ratings for Natco Pharma's various debt instruments.